Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

dia

Navigating the new Clinical Trial Regulation with DIA

November 14, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, dia, drugs, pharma, pharmaceutical

For those stakeholders involved with clinical trials in Europe, the new Clinical Trial Regulation to be introduced in 2019 will …
News
bi_german_building_at_night

Boehringer celebrates EU approval of Humira biosimilar

November 14, 2017 Manufacturing and Production, Sales and Marketing Boehringer, Boehringer Ingelheim, Cyltezo, EU, Europe, European Commission, Humira, biosimilar

Boehringer Ingelheim has announced that Cyltezo, its biosimilar of Abbvie’s Humira, has received marketing authorisation approval from the European Commission, …
News
albert-bourla_300x170px

Pfizer creates COO role so CEO Ian Read can focus on deal-making

November 14, 2017 Manufacturing and Production, Sales and Marketing Image Credit: Pfizer

In a sizeable shake-up of its business operations, Pfizer has promoted Albert Bourla (pictured) to the role of Chief Operating …
News

Hansa Medical mourns death of CEO

November 13, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Hansa Medical, pharma

Swedish biopharma firm Hansa Medical broke tragic and unexpected news in November when it announced the death of its CEO …
Appointment
1707_eu-agencies_relocations_website

EMA Headquarters: There’s no place like home

November 13, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, biotech, brexit, drugs, pharma, pharmaceutical

With the result of the Brexit referendum, the future of the EMA’s London headquarters was cast in doubt. Now, 19 …
Feature
hero-plus

Mylan to withdraw from Tel Aviv Stock Exchange

November 13, 2017 Sales and Marketing Mylan, TASE, pharma

US drug maker Mylan has announced its intention to withdraw from the Tel Aviv Stock Exchange (TASE), ending its involvement …
News
novartis_window

Novartis touts longer-lasting AMD rival to Eylea

November 13, 2017 Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical

Novartis posted strong results for its wet age-related macular degeneration (AMD) drug, by showing superiority against Eylea in Phase 3 …
News
roche_dark_0

EMA recommends approval of Roche’s Ocrevus in relapsing forms of multiple sclerosis

November 13, 2017 Sales and Marketing MS, Ocrevus, Roche, multiple sclerosis, pharma

Roche has revealed that its humanised monoclonal antibody Ocrevus (ocrelizumab) received a positive recommendation from the Committee for Medical Products …
News
weight-2036971_960_720

UK rates of obesity increased by 92% over two decades

November 13, 2017 Research and Development, Sales and Marketing OECD, biotech, drugs, obesity, pharma, pharmaceutical

A recent report by the OECD shares concerns that the UK’s overall health looks set to face a crisis due …
News
nigeria

Nigerian agency strongly contests that 70% of drugs are fake

November 13, 2017 Manufacturing and Production, Sales and Marketing Nigeria, biotech, drugs, pharma, pharmaceutical, pwC

Nigeria’s drug regulatory body has fiercely countered claims made by Chief Economist of PwC in West Africa, Andrew Nevin, that …
News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

November 10, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing pharmafile, top ten

Friday again, and we bring you the most read articles on our site this week – one of which was …
News
dynavax

Hep-B vaccine four-year battle for FDA approval is finally won

November 10, 2017 Medical Communications, Sales and Marketing biotech, drugs, dynavax, hepatitis B, pharma, pharmaceutical

Dynavax had said it was the last throw of the dice for its hepatitis B vaccine, Hepislav-B – the data …
News
sanofi_new_paris_hq

Sanofi signs $805 million deal for MS drug

November 10, 2017 Medical Communications, Sales and Marketing Principia Biopharma, Sanofi, biotech, drugs, pharma, pharmaceutical

Sanofi has decided to build its pipeline in neurological disorders with the agreement to develop Principia Biopharma’s BTK inhibitor candidate …
News

Recipharm Interim report January – September 2017

November 9, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Recipharm

Interim report January – September 2017 July – September 2017    
News
Press release

Recipharm to end operations in two facilities in Sweden

November 9, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Recipharm

Recipharm today announces that it will initiate a process with the intention of discontinuing manufacturing operations at its facilities in …
News
Press release
The Gateway to Local Adoption Series

Latest content

Five Facts about the menopause

March 6, 2026

Zello Appoints Kevin Bailey as Group Chief Medical Officer

March 6, 2026

BioDuro establishes joint manufacturing venture with Cenra

March 6, 2026

Symbiosis appoints Joanne Anderson as Chief Commercial Officer

March 6, 2026

Secarna Pharmaceuticals and Curie.Bio expand existing partnership

March 6, 2026